BioAge and Novartis collaborate to identify drug targets for aging-related diseases, with potential funding of $550M.Quiver AI SummaryBioAge Labs, Inc. has announced a multi-year research collaboration...
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.84%. Stocks on Monday...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.45%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.65%. Stocks today are under pressure,...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.12%. Stocks today are slightly...
BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.
BioAge Labs will present its advancements in metabolic disease therapies at the Goldman Sachs Catalyst Clinic on December 19, 2024.Quiver AI SummaryBioAge Labs, a clinical-stage biopharmaceutical company...
BioAge Labs will present at two investor conferences in December 2024, focusing on aging-related metabolic disease therapies.Quiver AI SummaryBioAge Labs, a clinical-stage biopharmaceutical company focused...